Colgate-Palmolive Company (CL) Shares Bought by Vantage Investment Advisors LLC
Vantage Investment Advisors LLC lifted its stake in Colgate-Palmolive Company (NYSE:CL) by 1.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,859 shares of the company’s stock after acquiring an additional 73 shares during the period. Vantage Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $360,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently modified their holdings of CL. American Beacon Advisors Inc. acquired a new stake in Colgate-Palmolive during the first quarter valued at approximately $102,000. Proficio Capital Partners LLC lifted its stake in Colgate-Palmolive by 16.9% during the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after purchasing an additional 207 shares during the last quarter. OLD Second National Bank of Aurora acquired a new stake in Colgate-Palmolive during the second quarter valued at approximately $109,000. Harbour Capital Advisors LLC acquired a new stake in Colgate-Palmolive during the first quarter valued at approximately $121,000. Finally, Hanson & Doremus Investment Management lifted its stake in Colgate-Palmolive by 4.5% during the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after purchasing an additional 70 shares during the last quarter. 73.87% of the stock is owned by institutional investors.
In other news, Director Stephen I. Sadove sold 20,780 shares of the firm’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the transaction, the director now directly owns 36,268 shares of the company’s stock, valued at approximately $2,557,619.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $71.45, for a total transaction of $273,867.85. Following the transaction, the insider now directly owns 53,173 shares of the company’s stock, valued at $3,799,210.85. The disclosure for this sale can be found here. 1.02% of the stock is owned by corporate insiders.
Colgate-Palmolive Company (NYSE CL) opened at $73.21 on Monday. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The stock has a market cap of $64,286.08, a price-to-earnings ratio of 25.51, a P/E/G ratio of 3.35 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same period in the prior year, the firm earned $0.73 EPS. The business’s revenue was up 2.8% on a year-over-year basis. equities analysts anticipate that Colgate-Palmolive Company will post 2.88 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date is Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.
CL has been the subject of several research analyst reports. Citigroup Inc. reduced their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research report on Thursday, November 2nd. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a research report on Monday, October 23rd. SunTrust Banks, Inc. upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price target for the company from $65.00 to $85.00 in a research report on Wednesday, October 11th. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Finally, Jefferies Group LLC restated a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a research report on Thursday, September 28th. One analyst has rated the stock with a sell rating, fifteen have given a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $76.67.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.